S

Shandong Boan Biotechnology Co Ltd
HKEX:6955

Watchlist Manager
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Watchlist
Price: 12.46 HKD 5.41% Market Closed
Market Cap: 6.7B HKD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+23%
Revenue
Forecast
+20%
Operating Income
Forecast
+68%
Net Income
Forecast
N/A

Wall Street
Price Targets

Price Targets Summary
Shandong Boan Biotechnology Co Ltd

Wall Street analysts forecast Shandong Boan Biotechnology Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Boan Biotechnology Co Ltd is 10.4 HKD with a low forecast of 10.3 HKD and a high forecast of 10.71 HKD.

Lowest Forecast
Wall Street Target
10.3 HKD
17% Downside
Average Forecast
Wall Street Target
10.4 HKD
17% Downside
Highest Forecast
Wall Street Target
10.71 HKD
14% Downside
Lowest
Price Target
10.3 HKD
17% Downside
Average
Price Target
10.4 HKD
17% Downside
Highest
Price Target
10.71 HKD
14% Downside
Shandong Boan Biotechnology Co Ltd Competitors:
Price Targets
RYTM
Rhythm Pharmaceuticals Inc
39% Upside
CVAC
CureVac NV
55% Upside
AMGN
Amgen Inc
12% Upside
4587
PeptiDream Inc
116% Upside
RYTM
Rhythm Pharmaceuticals Inc
39% Upside
CVAC
CureVac NV
55% Upside
AMGN
Amgen Inc
12% Upside
4587
PeptiDream Inc
116% Upside
W
300142
Walvax Biotechnology Co Ltd
11% Downside
CRSP
CRISPR Therapeutics AG
121% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
6% Upside
IVA
Inventiva SA
212% Upside

Revenue
Forecast

Revenue Estimate
Shandong Boan Biotechnology Co Ltd

For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.

66%
Past Growth
33%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shandong Boan Biotechnology Co Ltd

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's operating income for the next 2 years is 35%.

N/A
Past Growth
35%
Estimated Growth
Estimates Accuracy
56%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shandong Boan Biotechnology Co Ltd

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's net income for the next 2 years is 63%.

N/A
Past Growth
63%
Estimated Growth
Estimates Accuracy
-19%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shandong Boan Biotechnology Co Ltd's stock price target?
Price Target
10.4 HKD

According to Wall Street analysts, the average 1-year price target for Shandong Boan Biotechnology Co Ltd is 10.4 HKD with a low forecast of 10.3 HKD and a high forecast of 10.71 HKD.

What is Shandong Boan Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
33%

For the last 3 years the compound annual growth rate for Shandong Boan Biotechnology Co Ltd's revenue is 66%. The projected CAGR for the next 2 years is 33%.

What is Shandong Boan Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
35%

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's operating income for the next 2 years is 35%.

What is Shandong Boan Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
63%

The compound annual growth rate of Shandong Boan Biotechnology Co Ltd's net income for the next 2 years is 63%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.